February 26, 2018 / 3:06 AM / 10 months ago

BRIEF-Sam Chun Dang Pharm signs contract worth 3.17 bln won

Feb 26 (Reuters) - Sam Chun Dang Pharm Co Ltd :

* Says it signed a 3.17 billion won contract with Omnivision GMBH to provide collyrium incrementally modified drug in Europe

Source text in Korean: goo.gl/tuWiZm

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below